https://www.cancernetwork.com/view/angela-demichele-md-msce-analyzes-data-thus-far-from-i-spy2-in-hr-her2-early-breast-cancer
0
0
9/4/22 at 2:00pm
Organization
Cancernetwork.com
47 words
0
Comments
Angela DeMichele, MD, MSCE, discussed how the phase 2 I-SPY2 trial in patients with early breast cancer is informing patient therapy decisions in difficult-to-treat situations.
You are the first to view
Create an account
or login to join the discussion